chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Low grade fever for nine days, swelling at injection site, in day nine patient displayed a rash beginning on trunk and spreading along limbs. Displayed immediate speech regression (reduction in vocabulary volume for approximately 4 months post vaccination). Head banging on floor began on 10/9/2019 for roughly 4 month timeframe.
Patient received second dose Moderna vaccine  Feb 6  days ago in right arm Noticed some numbness lip that evening Had generalized aches,  "brain fog" for five days Then 5 days after vaccination  noticed pins and needles in cheek just on left side; she has sensation--but not as much as on right side of face More tingling worse with brushing teeth--has sensation like anesthetic is wearing off Seems slightly better today. Patient is not highly concerned but wanted it reported to CDC.  Physical exam not consistent with motor paralysis of Bells palsy; neuro exam WNL except slightly decreased sensation to light touch right forehead and cheek versus left; not progressing, mild.
A couple days after taking the 2nd vaccine for Covid 19 I experienced a horrible itching rash. I have seen numerous doctors about still no treatment has cured it completely.
First I got sick to my stomach and extreme diarrhea before midnight. Then I had tremendous pain in my leg that felt like blood cot. I've had them in the past and I was pretty certain I had one. So I put hospital stockings on. I called the hospital and they wanted me to come in but I didn't think it was safe so. Then I went on CDC site and couldn't find anything about blood cot. The next morning I had a extreme headache. In the past with blood cot I would put heat and stockings on and watched to see if it would go away. The following Monday I went to the Doctor and he said his wife had a similar reaction to the vaccine. I have a history of Phlebitis, blood cots in my legs but I haven't had one for probably 20 years. When it was gone it was gone just as quickly.
9 days after receiving my second dose, I developed a fever of 100.6, also had body aches.  They only lasted about 12 hours.   I had the normal side effects of arm pain and fatigue in the 24 hours immediately following the second dose.  The delayed nature of the fever was puzzling.  I did go in for a covid test, I had a rapid test (negative), antibody test (negative for IgM , positive for IgG), and the PCR test was negative.  The PCR test also testing for things such as influenza and several other viruses, all were negative.  I am suspicious of this somehow being a delayed effect from the vaccine.
Pt recvd vax & devel swelling @ inject site & sweating; 2 days later devel worsening of prev sx accompanied by nausea & vomiting;
Per Client, received second dose of Moderna COVID 19 vaccine in the left arm on 10/26/2021. Next day on 10/27/2021, left arm at site swollen and painful. Later in day on 10/27/2021, symptoms of  fever, runny nose, slight loss of taste and smell, fatigue, intermittent cough and slight chest discomfort, for now over a week since vaccine on 10/26/2021. Client dose have underlying medical conditions and taking prescription medications. Client reported taking over the counter Tylenol for pain and fever. PHN provided COVID 19 vaccine education with Client. PHN recommend that Client follow up with PCP, go into Urgent Care, ER or call 911 for medical emergency. Per Client, will be follow up with PCP and COVID 19 test
Tinnitus has become much worse.  Instead of a pesky mosquito, is now more like teapot
Pt awakened at about 1AM on 14AUG91 w/restlessness, temp 104; n/v x 2; soreness at site of DTP; mom gave APAP & cloth to site; Seems better but still feverish;
LEG PAIN; This spontaneous report received from a patient concerned a 70 year old female. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination.  The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the subject experienced leg pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of leg pain was not reported. This report was non-serious.
REMOTE BRANCH RETINAL ARTERY OCCLUSION IN LEFT EYE; ACUTE MACULAR NEURORETINOPATHY; This spontaneous report was received from literature: This report concerned a female of middle age group. The patient's race and ethnic origin was not reported. The objective of this study was to describe COVID-19, COVID-19 Vaccinations, and Subsequent Abnormalities in the Retina Causation or Coincidence. The patient's height, and weight were not reported. The patient's concurrent conditions included: diabetes, hypertension, and systemic vasculopathy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, frequency 1 total, start therapy date were not reported for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, two weeks after the vaccination, the patient experienced remote branch retinal artery occlusion in left eye, and acute macular neuroretinopathy (AMN). Laboratory data (dates unspecified) included: Optical coherence tomography (NR: not provided) acute macular neuroretinopathy. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the remote branch retinal artery occlusion in left eye and acute macular neuroretinopathy was not reported. The authors emphasized on the awareness for surveillance for adverse events following the vaccinations which was required in clinical trials and common adverse events were detected. This report was serious (Other Medically Important Condition).; Sender's Comments: V0. 20210910342-COVID-19 VACCINE AD26.COV2.S.- Remote branch retinal artery occlusion in left eye, acute macular neuroretinopathy. This events is considered not related. The events has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the events than the drug. Specifically: MEDICAL HISTORY.
Chills; Nausea; Vomiting; Fatigue; Joint pain; Headache; Fever of 101.5; This spontaneous case was reported by an other and describes the occurrence of CHILLS (Chills), NAUSEA (Nausea), VOMITING (Vomiting), FATIGUE (Fatigue) and ARTHRALGIA (Joint pain) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHILLS (Chills), NAUSEA (Nausea), VOMITING (Vomiting), FATIGUE (Fatigue), ARTHRALGIA (Joint pain), HEADACHE (Headache) and PYREXIA (Fever of 101.5). At the time of the report, CHILLS (Chills), NAUSEA (Nausea), VOMITING (Vomiting), FATIGUE (Fatigue), ARTHRALGIA (Joint pain), HEADACHE (Headache) and PYREXIA (Fever of 101.5) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant product use was reported No treatment information was provided; Sender's Comments: Based on the current available information which shows a temporal association between the use of mRNA-1273 and the onset of the other events, a causal relationship cannot be excluded.  The reported events are consistent with the product known safety profile
Neuropathy; Cant walk after 3rd vax; This is a spontaneous report received from a contactable reporter (consumer). The reporter is the patient.  A 51-year-old female patient (not pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), administered in arm right, administration date 22Dec2021 12:00 (Batch/Lot number: unknown) at the age of 51-years as dose 3 (booster), single for COVID-19 immunisation. Relevant medical history included: "Depression" (unspecified if ongoing). The patient has no known allergies. Prior to vaccination, she was not diagnosed with COVID-19 and since the vaccination, she has not been tested for COVID-19. There were no concomitant medications. She did not any other vaccines within 4 weeks prior to the COVID vaccine. Vaccination history included: BNT162B2 (administered in left arm as dose 1, single), for COVID-19 immunisation, reaction: "Neuropathy" and BNT162B2 (administered in left arm as dose 2, single), for COVID-19 immunisation, reaction: "Neuropathy." The following information was reported: NEUROPATHY PERIPHERAL (medically significant), outcome "not recovered", described as "Neuropathy" and GAIT INABILITY (non-serious), outcome "not recovered", described as "Cant walk after 3rd vax". The events "neuropathy" and "cant walk after 3rd vax" were evaluated at the physician office visit. Therapeutic measures were not taken as a result of neuropathy peripheral and gait inability.  The lot number for BNT162B2 was not provided and will be requested during follow-up.
Information has been received from a physician concerning a 3 month old male with no medical history or allergies who was vaccinated with a first and second dose of Hib conj vaccine on 29-JUN-2006 and 13-OCT-2006 (lot # 652711/1191R). Suspect vaccination administered 13-OCT-2006 included a dose of ACTHIB. There was no illness at the time of vaccination. On 16-OCT-2006 at 9PM he developed blood in stool/diaper and daily since then. Medical attention was sought. A stool hematocrit test was positive. At the time of the report the patient had not recovered. The patient had no adverse events following prior vaccination. There was no product quality complaint involved. The patient's sibling (WAES#0610USA12053) experienced a similar reaction after vaccination with hepatitis B virus vaccine rHBsAg (yeast) (manufacturer unknown) and Hib conj vaccine (manufacturer unknown).
5 days after Shingles vaccine pain in multiple muscles, that has increased in intensity and has not subsided. I do have a condition that causes muscle pain, but these are sharp and pronounced since the vaccine. Have been forced to take painkillers which I had avoided.
Patient came for premedication with Benadryl before the shot. Received Benadryl at 1659.
shingles; This is a spontaneous report from a contactable pharmacist. A male patient of an unspecified age received first dose of BNT162B2 (FIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection: Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date in Mar2021 at dose 1, single for covid-19 immunisation. Medical history and concomitant medications were not reported. On an unspecified date in Mar2021 the patient experienced shingles. Reporter is a pharmacist calling on behalf of a patient who received the Pfizer Covid vaccine in Mar2021, developed shingles and was treated and now would like the second dose of the Pfizer Covid vaccine. Is it safe for the patient to receive the Pfizer Covid vaccine after having shingles. a patient of unknow age who developed shingles between 1st and second dose, and now has been greater than 42 days between doses. Spoke from Covid-19 Vaccine use of antivirals and antibiotics at vaccination: Pfizer Medical Information is not aware of any specific information suggesting that you cannot be vaccinated with the Pfizer-BioNTech COVID-19 Vac-cine if you are taking an antiviral (such as acyclovir or valacyclovir) or an antibiotic (such as amoxicillin or azithromycin). Patient received treatment for the adverse event. Outcome of the event of the was unknown.   Information on the lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021828823 similar report from same reporter
can't breathe; her back and chest had the red rash; glands in her neck were tender for about 4 or 5 days; upper lip swelled; had a hard time swallowing; This is a spontaneous report from a contactable consumer. A 70-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Batch/Lot number Expiry date, number was not reported), via an unspecified route of administration, administered in Arm Right on 10Feb2021 00:45 (Age at vaccination 70-years-old) as dose 1, single for covid-19 immunisation. Medical history included cancer, allergic to penicillin and sulfars, and caller had 3 eye surgeries in 8 months and she was given a couple eye drops that she had horrible reactions tofrom from an unknown date and unknown if ongoing. The patient's concomitant medications, she takes a high blood pressure medicine, that is a beta blocker, and some cholesterol drugs, and eye drops, but caller did not take anything the same day as her COVID vaccine that was unusual. No further details, or product names, were provided by the caller. Caller explained she had a reaction to the first dose of the Pfizer-BioNTech COVID-19 vaccine and is scheduled to receive the second dose of the vaccine this Wednesday. She asked Can I take Benadryl before of after this second injection. Caller states that she is going for her second shot Wednesday at the hospital, and she is kind of nervous to take the second dose. Caller states that she is allergic to penicillins, she swells up and can't breathe and gets hives. Caller states that she had the same thing happen with this vaccine, about 24 hours after getting the injection, her upper lip swelled, she had a hard time swallowing on 11Feb2021, and her back and chest had the red rash. Caller states that it lasted about an hour, but now she is kind of nervous to take the second shot and she is wondering if it is okay to take Benadryl before or after getting the shot. Caller had her shot on 10Feb2021, and it was about 24 hours later that her symptoms occurred. Caller reports that most of her symptoms resolved within an hour, but her glands in her neck were tender for about 4 or 5 days following her side effects. Patient had no other vaccines on the same day as the suspect product. Patient considered going to the ER, but her symptoms resolved within an hour. Prior Vaccinations, the patient had not received any other vaccine within 4 weeks. The outcome of events her back and chest had the red rash and hard time swallowing was recovered on 11Feb2021, hard time swallowing was recovered on unspecified date and rest of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
No additional AE; the vaccine was going through temperature excursions since 1NOV2020 through the end of Feb 2021 and it was administered to patients during that time; This spontaneous report was received from a nurse and refers to a patient of unknown age. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided.  On 03-FEB-2021 the patient was vaccinated with dose of improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) lot # S027465, expiration date: 02-MAR-202, 0.5 milliliter (formulation, strength, frequency and route of administration were not reported) for prophylaxis. On an unknown dates between 01-NOV-2020 and the end of February 2021, the dose of the vaccine was exposed to unspecified multiple temperature excursions. The call was due to digital data logger. No additional adverse event was reported.
Approximately 4 hours after injection pt experienced headache, dizziness, diaphoretic and vision went temporarily. "Couldn't see her hands while typing on computer". Pt returned to clinic, was evaluated. No tx given or prescribed.
Information has been received from a nurse concerning unspecified patients of unknown age and gender. On unspecified dates, the patients were administered with M-M-R II injection (dose and route not provided, lot # L009544 with expire date of 19-MAR-2017), which was exposed to temperatures outside of the recommended range (Incorrect product storage). The conditions storage was 11 Celsius degree for 1333 hours, 41 minutes. There was no previous temperature excursion. No adverse effects have been reported. Additional information has been requested.
Vaccination site pain; Arm was itchy; Erythema; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Arm was itchy), ERYTHEMA (Erythema) and VACCINATION SITE PAIN (Vaccination site pain) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced PRURITUS (Arm was itchy) and ERYTHEMA (Erythema). On an unknown date, the patient experienced VACCINATION SITE PAIN (Vaccination site pain). At the time of the report, PRURITUS (Arm was itchy), ERYTHEMA (Erythema) and VACCINATION SITE PAIN (Vaccination site pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The  concomitant medications on use were not provided.  No treatment information was provided.
Fever; Chills; headache; adverse events after getting the third dose of the Pfizer BioNtech covid-19 Vaccine; adverse events after getting the third dose of the Pfizer BioNtech covid-19 Vaccine; a low platelet count; This is a spontaneous report from a contactable consumer (patient herself). A 69-years-old female patient received bnt162b2 (BNT162B2, formulation: solution for injection, lot number: not reported, expiry date: not reported), via an unspecified route of administration on 08Sep2021 (at the age of 69-years-old) as dose 3, single for COVID-19 immunization. Medical history included ongoing low immune system. Patient had 1st and 2nd dose of BNT162B2 on an unspecified date for COVID-19 immunization and after 2nd dose patient had fever, chills and headache. The patient's concomitant medications were not reported. On 08Sep2021, the patient experienced fever, chills, headache, adverse events after getting the third dose of the pfizer biontech COVID-19 vaccine. On an unspecified date in Sep2021, experienced a low platelet count. Patient had COVID-19 Vaccine on Wednesday morning 08Sep2021, and later that night, she started experiencing chills, (woke up with chills), yesterday experienced headache and fever with body temperature of 101F, she took a number medications (Tylenol, Ibuprofen and aceterin) as therapeutic measure for the events fever chills and headache. Patient was fine for the rest of last night. Earlier, she got a body temperature of 99.1F and it went back to 100F with a bit of headache. The patient underwent lab tests and procedures on an unspecified date in Sep2021 which included body temperature: 101 fahrenheit, body temperature: 99.1 fahrenheit, body temperature: 100 fahrenheit and platelet count: low on an unspecified date. She was seeing a hematologist because she has a low platelet count. The outcome of event chills was recovered on an unspecified date in Sep2021 and all other events was reported as unknown.   Information on lot number has been requested during follow up.
On the evening of 07/07/2022 started running low grade fever from then until 07/11/2022. On 07/12/22 fever spiked up to 102.9 and the on the evening of  07/12/2022 she had stomach ache, fever up to 105.0, fatigued and low urine out put. She was taken to the ER at the Hospital and had normal blood and urine cultures.  The Lyme/Tick cultures are still out and have not received the results yet. As of today she is still running a 99.0 fever.
Chills and 101.9 fever started around 1:45 pm on Tuesday April 6, 2021.  I took Tylenol around 4:00pm on April 6th.  The fever was down to 100.7 around 9:00pm on April 6th.  Temperature was normal (97.8) at 6:30 am on Wednesday April 7, 2021.  I felt tired and draggy in the morning of April 7th.  The tiredness  went away by 3:00pm on Wednesday April 7th.  I have felt great every sense.
Body aches. Headache.  Started morning after being vaccinated. Then had tachycardia with heart rate reaching 165 at rest. Heart palpitations lasted two hours. During heart palpitations body seized/locked up. Couldn?t move arms and legs. Felt numb to touch. Face also seized. Rapid breathing/ shortness of breath. Remained seized for about 45 minutes. EMS arrived at end of seizing. Very unstable standing and walking.
Left lymph nodes by collar bone are swollen; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 13 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 06Jul2021 (Lot number: EW0181) at the age of 13 years as dose 2,single for covid-19 immunization. Relevant medical history included: "Known allergies: Tree Nuts" (unspecified if ongoing). Concomitant medication(s) included: XYZAL. Past drug history included: Pcn, reaction(s): "Known allergies". Vaccination history included: Bnt162b2 (Dose: 1st , Time: 16:05pm, Anatomical site of Injection: left upper arm, Batch/Lot number: EWQ181), administration date: 15Jun2021, for COVID-19 immunisation. The following information was reported: LYMPHADENOPATHY (non-serious) with onset 07Jul2021 14:15, outcome "recovering", described as "Left lymph nodes by collar bone are swollen". Therapeutic measures were not taken as a result of lymphadenopathy.  Additional Information: The Facility where the most recent COVID-19 vaccine was administered: Pharmacy or Drug Store. The patient hadn't received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient hadn't diagnosed with COVID-19 and since the vaccination, the patient hadn't been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
Pt. Describes difficulty clearing throat and voice changing. Eventually progressed to tightness in throat difficultly breathing.
This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown age and gender. On an unspecified date, the patients may have received improperly stored doses of GARDASIL intramuscularly (dose and lot number were not reported). The vaccines were improperly exposed to 48.5F for 5 hours 49 minutes (on 01-FEB-2015), and to 48.5F for 9 hours 44 minutes (on 02-FEB-2015), and to room temperatures <77F for 31 minutes (on 24-FEB-2015) for 16 minutes (on 16-FEB-2015) for 15 minutes (on 09-FEB-2015) for 15 minutes (on 06-FEB-2015) for 24 minutes (on 30-JAN-2015) for 31 minutes (on 27-JAN-2015) for 40 minutes (on 15-JAN-2015) for 16 minutes (on 06-JAN-2015) and for 54 minutes (on 30-DEC-2014). There was no adverse effects reported. This is one of several reports received from the same reporter. Additional information has been requested.
7/20/11 injection site began to itch, became red & raised. Area surrounding inj. site was smaller (18mm x 50mm) and dkr pink, surrounding that was a lighter pink area (3.5" x 4.5"). Dr. advised warm compresses 3-4 x/day, OTC ZYRTEC or CLARITIN, & topical HCT 1% crm. Reaction resolved by 7/26/11.
pt recvd vax;immed p/ area became inflammed,confluent flat,warm to touch otherwise nl;area approx 1 1/4" diam;ice applied x 15 mins;no longer warm,dec area of erythema to 1/2" diam diffuse;